This article describes the management of deep vein thrombosis (DVT) using an ambulatory nurse-led pathway and the compression technique using duplex ultrasound. This pathway permits the management of the “walking wounded” as well as other patients at varying risks of having DVT and in so doing has changed the approach toward the management of this common clinical event. The success of the described pathway is attributed to the development of low molecular weight heparin and the reliability of diagnostics.
Wells PS
, Anderson A, Bormanis J.Value of pretest probability in deep vein thrombosis in clinical management. Lancet1997;350 (9094):1795-1798.
2.
Mani R
, Regan F, Sheridan J, Batty V.Duplex ultrasound scanning for diagnosing deep vein thrombosis. J Dermatol Surg1995;21(4):322-326.
3.
van Dongen CJJ
, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. In: Cochrane database of systematic reviews. Issue 4. UK; 2004.
4.
Seethram K
, Okun N.Low molecular weight heparin versus unfractionated heparin for the treatment of venous thromboembolism in pregnancy. In: Cochrane database of systematic reviews. Issue 3. UK; 2004.
5.
Hyers TM
, Hull RD, Morris TA, Tapson V.Antithrombotic therapy for venous thromboembolic disease. Chest2001;119:176S-193S.
6.
van Dongen CJ
, Mac Gillavry MR, Prins MH. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. In: Cochrane database of systematic reviews. Issue 4. UK; 2004.
7.
Datapharm Communications. Aventis
. Summary of product characteristics for Clexane (Enoxaparin). Surrey, UK: Datapharm Communications; 2004. Retrieved February 21, 2005, from www.medicines.org.uk
8.
Scottish Intercollegiate Guidelines Network (SIGN) Thrombosis prophylaxis
. Pregnancy and puerperium. Retrieved April 15, 2005, from www.sign.ac.uk/guidelines/fulltext/62/section9.html
9.
van der Heijden JF
, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. In: Cochrane database of systematic reviews. Issue 3. UK; 2004.
10.
Ginsberg J.Use of antithrombotic agents during pregnancy
. Chest2004;1191:5-6.
11.
Hirsch J.Heparin and low-molecular-weight heparin
. Chest2004;119(1):30-31.
12.
Hull RD
, Carter CJ, Jay RM, et al.The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Circulation1983; 67(4):901-905.
13.
Hogg K
, Ashton A.Antithrombotic treatment of below knee deep vein thrombosis. Emerg Med J2003;20:364-365.
